International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Effect of Non-Hormonal Treatment on Uterine Leiomyoma

Ramona Perhar, Osheen Bonal, Meena Dayal, Amrita Chaurasia, Rita Shukla

Abstract: AIM: To evaluate the efficacy of Non-Hormonal drugs on Uterine Leiomyoma METHOD: The study was conducted on sixty women of age 20-50 yrs with Leiomyoma. All cases were randomly divided into three groups, Group 1 received 25mg Mifepristone once daily, Group 2 received Ormeloxifene 60mg biweekly and group 3 received Tripterygium wilfordii 30mg with Vitamin D 1000IU twice daily orally for 6 months. The efficacy of the drugs were analyzed by comparing the pre- treatment and post-treatment reduction in size of Leiomyoma, Pictorial blood assessment chart (PBAC), Visual Analogue Score (VAS), Haemoglobin level and Endometrial Thickness (ET). RESULT: A statistically significant reduction in PBAC score in group1 (p

Keywords: Leiomyoma Mifepristone Ormeloxifene Tripterygium Wilfordii

How to Cite?: Ramona Perhar, Osheen Bonal, Meena Dayal, Amrita Chaurasia, Rita Shukla, "Effect of Non-Hormonal Treatment on Uterine Leiomyoma", Volume 8 Issue 7, July 2019, International Journal of Science and Research (IJSR), Pages: 1240-1244, https://www.ijsr.net/getabstract.php?paperid=ART20199825, DOI: https://dx.doi.org/10.21275/ART20199825

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.